Cargando…

Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell Populations

Two human natural killer (NK) cell subsets are usually distinguished, displaying the CD56(dim)CD16(+) and the CD56(bright)CD16(−/+) phenotype. This distinction is based on NK cells present in blood, where the CD56(dim) NK cells predominate. However, CD56(bright) NK cells outnumber CD56(dim) NK cells...

Descripción completa

Detalles Bibliográficos
Autores principales:	Melsen, Janine E., Lugthart, Gertjan, Lankester, Arjan C., Schilham, Marco W.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927633/ https://www.ncbi.nlm.nih.gov/pubmed/27446091 http://dx.doi.org/10.3389/fimmu.2016.00262

Ejemplares similares

Human Bone Marrow-Resident Natural Killer Cells Have a Unique Transcriptional Profile and Resemble Resident Memory CD8(+) T Cells
por: Melsen, Janine E., et al.
Publicado: (2018)

Single-cell transcriptomics in bone marrow delineates CD56(dim)GranzymeK(+) subset as intermediate stage in NK cell differentiation
por: Melsen, Janine E., et al.
Publicado: (2022)

Distinct Signatures in the Receptor Repertoire Discriminate CD56bright and CD56dim Natural Killer Cells
por: Schwane, Vera, et al.
Publicado: (2020)

Hobit expression by a subset of human liver-resident CD56(bright) Natural Killer cells
por: Lunemann, Sebastian, et al.
Publicado: (2017)

Evaluation of CD56(dim) and CD56(bright) natural killer cells in peripheral blood of women with IVF failures
por: Mardanian, Farahnaz, et al.
Publicado: (2015)

CD56(bright) natural killer cells preferentially kill proliferating CD4(+) T cells
por: Lee, Mercede, et al.
Publicado: (2023)

Human Natural Killer Cell Maturation Defect Supports In Vivo CD56(bright) to CD56(dim) Lineage Development
por: Domaica, Carolina Inés, et al.
Publicado: (2012)

Interleukin (IL)-23 Stimulates IFN-γ Secretion by CD56(bright) Natural Killer Cells and Enhances IL-18-Driven Dendritic Cells Activation
por: Ziblat, Andrea, et al.
Publicado: (2018)

Human Hepatic CD56(bright) NK Cells Display a Tissue-Resident Transcriptional Profile and Enhanced Ability to Kill Allogenic CD8(+) T Cells
por: Jameson, Gráinne, et al.
Publicado: (2022)

CD56(bright) natural killer cells and response to daclizumab HYP in relapsing-remitting MS
por: Elkins, J., et al.
Publicado: (2015)

Intratumoral CD56(bright) natural killer cells are associated with improved survival in bladder cancer
por: Mukherjee, Neelam, et al.
Publicado: (2018)

Human CD56(dim)CD16(dim) Cells As an Individualized Natural Killer Cell Subset
por: Amand, Mathieu, et al.
Publicado: (2017)

CD56bright Natural Killer Cells: A Possible Biomarker of Different Treatments in Multiple Sclerosis
por: Laroni, Alice, et al.
Publicado: (2020)

The involvement of circulating CD69(+) CD56(bright) natural killer cells in weight loss before bariatric surgery: A retrospective cohort study
por: Chikuie, Emi, et al.
Publicado: (2023)

Natural Killer Cell Integrins and Their Functions in Tissue Residency
por: Shannon, Michael J., et al.
Publicado: (2021)

Cytotoxicity of Human Hepatic Intrasinusoidal CD56(bright) Natural Killer Cells against Hepatocellular Carcinoma Cells
por: Hwang, Shin, et al.
Publicado: (2019)

The phenotype of CD3–CD56(bright) and CD3–CD56(dim) natural killer cells in systemic lupus erythematosus patients and its relation to disease activity
por: Soelistyoningsih, Dwi, et al.
Publicado: (2022)

CD56(bright)CD16(-) natural killer cells as an important regulatory mechanism in chronic graft-versus-host disease
por: Lauener, Madeline P., et al.
Publicado: (2022)

Circulating growth/differentiation factor 15 is associated with human CD56(bright) natural killer cell dysfunction and nosocomial infection in severe systemic inflammation
por: Kleinertz, Holger, et al.
Publicado: (2019)

CD56(dim) CD16(−) Natural Killer Cell Profiling in Melanoma Patients Receiving a Cancer Vaccine and Interferon-α
por: Vujanovic, Lazar, et al.
Publicado: (2019)

Transcriptional Regulation of Mouse Tissue-Resident Natural Killer Cell Development
por: Valero-Pacheco, Nuriban, et al.
Publicado: (2020)

Natural Killer Cells Generated From Human Induced Pluripotent Stem Cells Mature to CD56(bright)CD16(+)NKp80(+/-) In-Vitro and Express KIR2DL2/DL3 and KIR3DL1
por: Euchner, Johanna, et al.
Publicado: (2021)

A long noncoding RNA positively regulates CD56 in human natural killer cells
por: Zhang, Ruya, et al.
Publicado: (2016)

CD300c is uniquely expressed on CD56(bright) Natural Killer Cells and differs from CD300a upon ligand recognition
por: Dimitrova, Milena, et al.
Publicado: (2016)

Corrigendum: Transcriptional Regulation of Mouse Tissue-Resident Natural Killer Cell Development
por: Valero-Pacheco, Nuriban, et al.
Publicado: (2020)

Recruited and Tissue-Resident Natural Killer Cells in the Lung During Infection and Cancer
por: Franklin, Miriam, et al.
Publicado: (2022)

CD56-Negative Extranodal Natural Killer/T-Cell Lymphoma: A Retrospective Study in 443 Patients Treated by Chemotherapy With or Without Asparaginase
por: Yang, Jing, et al.
Publicado: (2022)

Circulating CD56(bright) NK cells inversely correlate with survival of melanoma patients
por: de Jonge, Kaat, et al.
Publicado: (2019)

Single-cell profiling reveals periventricular CD56(bright) NK cell accumulation in multiple sclerosis
por: Rodríguez-Lorenzo, Sabela, et al.
Publicado: (2022)

Impact of polysialylated CD56 on natural killer cell cytotoxicity
por: Moebius, Jeannette M, et al.
Publicado: (2007)

Effects of infliximab on lung and circulating natural killer cells, CD56+ T cells and B cells in sarcoidosis
por: Kullberg, Susanna, et al.
Publicado: (2021)

The co-inhibitory receptor TIGIT regulates NK cell function and is upregulated in human intrahepatic CD56(bright) NK cells
por: Ziegler, Annerose E., et al.
Publicado: (2023)

Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56(bright) NKG2A(+++) Cells, and Yet Display Increased Degranulation and Higher Perforin Content
por: Dobbs, Kerry, et al.
Publicado: (2017)

Human Placental Cytotrophoblasts Attract Monocytes and Cd56(bright) Natural Killer Cells via the Actions of Monocyte Inflammatory Protein 1α
por: Drake, Penelope M., et al.
Publicado: (2001)

Shaping of CD56(bri) Natural Killer Cells in Patients With Steroid-Refractory/Resistant Acute Graft-vs.-Host Disease via Extracorporeal Photopheresis
por: Ni, Ming, et al.
Publicado: (2019)

Gradual Increase of FcγRIIIa/CD16a Expression and Shift toward IFN-γ Secretion during Differentiation of CD56(dim) Natural Killer Cells
por: Lajoie, Laurie, et al.
Publicado: (2017)

Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56(bright) NKG2A(+++) Cells, and Yet Display Increased Degranulation and Higher Perforin Content
por: Dobbs, Kerry, et al.
Publicado: (2017)

Normal Numbers of Stem Cell Memory T Cells Despite Strongly Reduced Naive T Cells Support Intact Memory T Cell Compartment in Ataxia Telangiectasia
por: Weitering, Thomas J., et al.
Publicado: (2021)

Invasive Surgery Impairs the Regulatory Function of Human CD56(bright) Natural Killer Cells in Response to Staphylococcus aureus. Suppression of Interferon-γ Synthesis
por: Reinhardt, Renate, et al.
Publicado: (2015)

Natural Killer Cell Development and Maturation Revisited: Possible Implications of a Novel Distinct Lin(−)CD34(+)DNAM-1(bright)CXCR4(+) Cell Progenitor
por: Bozzano, Federica, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_rupdocjfjquc25lmtvaudk5kpq